What Has Been the Growth of the Acute Ischemic Stroke Diagnosis Market So Far?
The acute ischemic stroke diagnosis market has seen considerable growth due to a variety of factors.
•In the previous years, the market for acute ischemic stroke diagnosis has seen significant growth. It is projected to increase from $2.32 billion in 2024 to $2.48 billion in 2025, posting a compound annual growth rate (CAGR) of 6.9%.
Factors such as the increase in cardiovascular risk factors, the use of telemedicine, the creation of stroke centers, the growing aging population, and the advancement of thrombolytic therapies have contributed to the growth seen during the historic period.
What Are the Future Growth Projections for the Acute Ischemic Stroke Diagnosis Market?
The acute ischemic stroke diagnosis market is expected to maintain its strong growth trajectory in upcoming years.
• There is anticipated robust expansion in the acute ischemic stroke diagnosis market in the coming years, surging to $3.27 billion by 2029 with a compound annual growth rate (CAGR) of 7.1%.
The growth predicted for this period is due largely to factors such as the incorporation of remote monitoring technologies, patient-focused healthcare models, integration of wearable gadgets, point-of-care testing devices, and the broader application of mobile stroke units. The projected period is expected to witness trends like advancements in imaging technologies, progress in artificial intelligence, innovations in genetic and biomarker products, blockchain implementation for data security, along with the integration of augmented reality.
Which Factors Are Boosting Growth In The Acute Ischemic Stroke Diagnosis Market?
As the number of acute ischemic stroke cases continues to rise, the acute ischemic stroke diagnosis market is set to experience significant growth. Acute ischemic stroke is a serious medical emergency caused by poor blood flow to the brain, leading to brain cell destruction. Early detection can help in treatment, minimizing brain damage and other stroke consequences. For example, the Stroke Association, a UK-based charity, published a manifesto in April 2024 showing that the cost of stroke in the UK is expected to increase from £43 billion next year to £75 billion by 2035. This represents almost a 200% growth over two decades. Additionally, one in four strokes impact people of working age, causing an annual productivity loss of £1.6 billion, projected to surge by 136% by 2035. Owing to this, the acute ischemic stroke diagnosis market's growth is being driven by the escalating instances of acute ischemic stroke.
What Key Areas Define The Segmentation Of The Global Acute Ischemic Stroke Diagnosis Market?
The acute ischemic stroke diagnosis market covered in this report is segmented –
1) By Diagnostic Type: Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics
2) By Surgery Type: Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy
3) By Application: Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive
Subsegments:
1) By Computed Tomography (CT): Non-Contrast CT, CT Angiography
2) By Magnetic Resonance Imaging (MRI): MRI With Diffusion-Weighted Imaging (DWI), MRI Angiography
3) By Carotid Ultrasound: Doppler Ultrasound, B-Mode Ultrasound
4) By Cerebral Angiography: Digital Subtraction Angiography (DSA), Catheter Angiography
5) By Electrocardiography (ECG): Standard ECG, Holter Monitoring
6) By Echocardiography: Transthoracic Echocardiography (TTE), Transesophageal Echocardiography (TEE)
7) By Other Diagnostics: Blood Tests, Neurological Examination, CT Perfusion
Pre-Book The Acute Ischemic Stroke Diagnosis Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Acute Ischemic Stroke Diagnosis Market?
The proliferation of product advancements is a key trend gaining traction in the acute ischemic stroke diagnosis market. Leading corporations in this market are developing and launching new products to retain their market standing. Take, for example, Imperative Care Inc., a US medical equipment producer that, in February 2022, introduced Zoom POD Aspiration Tubing - an innovative approach to enhance stroke therapy. The Zoom POD, as the singular sterile field clot filter device, makes it possible for ischemic stroke patients to undergo vital mechanical thrombectomy procedures more promptly. By being integrated within the aspiration tube, the Zoom POD minimizes the distance between aspiration and filtration while retaining complete aspiration power. It also expedites and streamlines the treatment process by enabling the physician to rapidly confirm the successful removal of the clot.
Who Are the Key Players in the Acute Ischemic Stroke Diagnosis Market?
Major companies operating in the acute ischemic stroke diagnosis market include:
• Cardinal Health Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Bayer AG
• Sanofi-Aventis LLC
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Philips Healthcare
• Stryker Corporation
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• Genentech Inc.
• Nihon Kohden Corporation
• Neusoft Medical Systems Co. Ltd.
• Penumbra Inc.
• Insera Therapeutics LLC
• MicroVention Inc.
• FUJIFILM Medical Systems
• Canon Medical Systems Corporation
• Silk Road Medical Inc.
• Samsung Neurologica Corporation
• Mentice AB
• NICO Corporation
• Imperative Care Inc.
• Olea Medical
• NovaSignal Corporation
• iSchemaView Inc.
• Hyperfine Research Inc.
• Perfuze Ltd.
What Is The Most Dominant Region In The Acute Ischemic Stroke Diagnosis Market?
North America was the largest region in the acute ischemic stroke diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
